Delivery Order SPE2DB22D1041-SPE2DB25FUBV6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,506.66 to AmerisourceBergen Drug Corp for 100 tablets of Depakote DR 250 mg on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-set-aside contract utilizes firm fixed-price pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Depakote DR 125 mg Sprinkle capsules (100-count packaging) with a ceiling value of $5,463.37. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 19, 2025, and performance to occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Depakote DR 125 mg sprinkle capsules (100 count) with a ceiling value of $3,165.70. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The contract is scheduled for ultimate completion on September 5, 2025, with performance taking place at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,015.34 to AmerisourceBergen Drug Corp for the supply of Depakote ER 250 mg tablets in quantities of 100 units. This firm fixed-price delivery order, issued on June 6, 2025, is scheduled for completion by June 9, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Depakote DR 125 mg Sprinkle capsules (100-count packaging) with a ceiling value of $1,921.72. The award was made on July 30, 2025, with a completion date of July 31, 2025, under a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Depakote DR 125 mg sprinkle capsules (100-count unit) valued at $1,458.55. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award utilized firm fixed pricing with no set-aside designation, reflecting...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,549.92, is for the delivery of DEPAKOTE DR 500 MG TABLET 100S, a neurological medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 16, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
- This federal contract award with the Defense Logistics Agency (DLA) Troop Support Medical was made to AmerisourceBergen Drug Corp for the delivery of Depakote ER 500 mg tablets. The $1,361.17 Firm Fixed Price Delivery Order has an ultimate completion date of August 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for providing a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order valued at $1,358.37 to AmerisourceBergen Drug Corp for 100 units of Depakote DR 125 mg Sprinkle capsules, with a completion deadline of July 21, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a direct procurement of pharmaceutical inventory to support federal healthcare operations. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Depakote DR 125 mg Sprinkle capsules (100-count bottles). This firm fixed-price delivery order, valued at $14,147.88, was competitively awarded without set-aside designation and carries an ultimate completion date of September 23, 2025. The product will be delivered to AmerisourceBergen's corporate office...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUBV6Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Depakote ER 500 mg tablets (100-count units) with a ceiling value of $1,357.91. This is a firm fixed-price, non-set-aside delivery order contract with an ultimate completion date of September 8, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a substantial prime contract vehicle valued at $999,999,999.00 that extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems. The company supplies a comprehensive range of pharmaceutical products and medical supplies through its DLA contracts, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Depakote ER, an anticonvulsant and mood-stabilizing medication, represents one of many pharmaceutical products the contractor delivers under its federal supply agreements. AmerisourceBergen's consistent receipt of competitively awarded, non-set-aside contracts demonstrates its established capability to meet federal procurement requirements across diverse therapeutic domains and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/5/25 |